A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease

Clinical trial NCT00069849 · TERMINATED

Trial details

NCT number: NCT00069849
Sponsor: Abbott
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2003-07-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.